A Stepwise Approach to Nasal Polyp Treatment is Emerging in the Age of Biologics
Science & Innovation Webinar
Webinar Recorded on May 12, 2021
Sponsored by Optinose
As patients with nasal polyps struggle with chronic symptoms and reduced quality of life, treatment costs rise. Due to the lack of symptom relief from historical treatments, patients often seek more costly options such as endoscopic sinus surgery or biologics. As additional biologics enter the market, costs may increase even more. Recently, a stepped-care approach to treatment has begun to emerge, where treatment options are informed by factors such as disease severity, risk-benefit assessment, cost, response to prior treatment, and patient preference.
During this webinar, experts will discuss this approach for stepped-care management of nasal polyps and what it may mean for payors. Specifically, the costs and potential impacts of intranasal steroids, surgery and biologics, will be discussed. With this information, payors may realize a useful, cost-effective management strategy for the treatment of nasal polyps.
- Michael J. Rothrock, BS, MBA, MHA
President, Allegheny Strategic Partners LLC
- Joseph Han, MD
President, American Rhinologic Society
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.